Product image of Montelucaste Vitória (Montelukast) supplied by GNH India

Montelucaste Vitória

Active Ingredient:
Montelukast
Origin:
EU

Montelucaste Vitória (Montelukast)

Montelukast, the active ingredient in Montelucaste Vitória, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is indicated for the management of asthma, allergic rhinitis and exercise‑induced bronchoconstriction in patients who require a non‑steroidal option.
GNH India supplies Montelucaste Vitória as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Faes Farma Portugal, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelukast acts on the leukotriene pathway to control airway inflammation and bronchoconstriction.

  • Asthma: helps prevent chronic symptoms and reduces the frequency of exacerbations.
  • Allergic rhinitis: alleviates nasal congestion, sneezing and itching caused by seasonal allergens.
  • Exercise‑induced bronchoconstriction: reduces airway narrowing that occurs during physical activity.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes from binding and triggering bronchoconstriction, mucus secretion, and inflammatory cell recruitment in the respiratory tract, thereby improving airway patency and reducing inflammation.

Side Effects

Montelucaste Vitória may cause a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate pain often reported.
  • Abdominal pain: discomfort or cramps in the stomach area.
  • Cough: occasional irritation of the throat.
  • Nausea: feeling of queasiness.
  • Dizziness: transient light‑headedness.
  • Fatigue: unusual tiredness.

Serious or Rare Side Effects

  • Allergic reactions: rash, angioedema or swelling.
  • Mood changes: depression, anxiety or suicidal thoughts.
  • Hepatic enzyme elevation: abnormal liver function tests.
  • Stevens‑Johnson syndrome: severe skin reaction.
  • Eosinophilic granulomatosis with polyangiitis: rare vasculitis.
  • Anaphylaxis: life‑threatening systemic allergic response.

Precautions & Warnings

When prescribing Montelucaste Vitória, clinicians should consider several safety measures.

  • Monitor asthma control: assess symptoms regularly to ensure adequate management.
  • Hypersensitivity: avoid in patients with known allergy to montelukast or any tablet excipients.
  • Liver impairment: use cautiously and monitor hepatic function.
  • Pregnancy: category unknown; discuss potential risks with a healthcare professional.
  • Concomitant drugs: review for possible interactions before initiating therapy.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Montelucaste Vitória can interact with other medicines, requiring attention to the interaction severity.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase montelukast plasma levels.
  • Phenobarbital: can reduce therapeutic effect by inducing metabolism.

Moderate Interactions (Monitor Closely)

  • CYP2C9 inhibitors (e.g., fluconazole): may modestly raise drug concentrations.
  • Other leukotriene modifiers: combined use can increase risk of adverse effects.
  • Warfarin: occasional reports of altered INR; monitor coagulation parameters.

Frequently Asked Questions

Montelucaste Vitória contains montelukast, a leukotriene receptor antagonist indicated for the long‑term management of asthma, relief of seasonal allergic rhinitis symptoms, and prevention of exercise‑induced bronchoconstriction in patients who need an oral, non‑steroidal option.

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes from causing bronchial smooth‑muscle contraction, mucus production and airway inflammation, which helps keep the airways open and reduces allergic symptoms.

The dose of Montelucaste Vitória is individualized by the prescribing clinician based on the patient’s age, condition severity and response to therapy. Patients should follow the exact regimen written on their prescription.

The pregnancy category for montelukast is not definitively established. Healthcare providers should weigh potential benefits against unknown risks and discuss options with pregnant or nursing patients before initiating therapy.

To request Montelucaste Vitória, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast offers an oral, non‑steroidal alternative that targets leukotriene‑mediated inflammation, whereas inhaled corticosteroids act directly on airway inflammation via glucocorticoid receptors. Montelukast is often used as add‑on therapy or for patients who cannot tolerate inhaled steroids, but it may be less potent for acute symptom control.

Montelucaste Vitória tablets should be stored below 25 °C in their original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

The medication is taken orally, usually once daily in the evening, with or without food. Tablets should be swallowed whole with a glass of water and not crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious adverse events include severe allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric effects like depression, anxiety, and suicidal thoughts. Rare but critical conditions such as Stevens‑Johnson syndrome or eosinophilic granulomatosis with polyangiitis have also been reported.

Montelucaste Vitória is contraindicated in individuals with known hypersensitivity to montelukast or any tablet excipients. Caution is advised for patients with severe liver impairment, and it should be avoided in those who have experienced serious allergic reactions to leukotriene‑modifying agents.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT